Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Relative Risk01:12

Relative Risk

139
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
139
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

124
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
124
Odds Ratio01:09

Odds Ratio

120
The odds ratio (OR) is a statistical measure used extensively in epidemiology and research to quantify the strength of association between exposure and outcome across different groups. Unlike relative risk, which compares the probabilities of an event occurring, the odds ratio compares the odds of an event occurring in the exposed group to the odds of it occurring in the unexposed group. The odds, in this context, are calculated as the probability of the event happening divided by the...
120
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

88
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
88
Hazard Ratio01:12

Hazard Ratio

107
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
107
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

168
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
168

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Structural features of the hippocampus covary with memory-guided attention depending on the side of hippocampal sclerosis.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

The therapeutic relationship in in-person, video call, and telephone psychotherapy sessions.

The British journal of clinical psychology·2026
Same author

A bidirectional two-sample Mendelian randomization study of immune responses against Epstein-Barr virus nuclear antigen 1 and multiple sclerosis in individuals of European ancestry.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Mindfulness-based stress reduction program improves psychological well-being and blood pressure in an Italian context: potential mechanisms and benefits.

Psychology, health & medicine·2025
Same author

Knockoff-Based Fine Mapping of MS-Associated SNPs in Sardinian Trios.

Biochemical genetics·2025
Same author

Association of Healthy Predominantly Plant-Based Diet with Reduced Cardiovascular Disease Incidence and Mortality and Development of Novel Heart-Protective Diet Index.

Nutrients·2025

Related Experiment Video

Updated: Jun 18, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K

Assessing Additive Interactions between Protective Factors Using Relative Risk Reduction Due to Interaction.

Andrea Nova1, Teresa Fazia1, Luisa Bernardinelli1

  • 1Department of Brain and Behavioral Sciences, University of Pavia, 27100 Pavia, Italy.

Medicina (Kaunas, Lithuania)
|July 27, 2024
PubMed
Summary

The Relative Risk Reduction due to Interaction (RRRI) measures synergistic effects of preventive factors. This new metric offers clearer interpretation for drug combinations and therapeutic interventions in disease prevention.

Keywords:
additive interactioneffect modificationmoderationprotective factorssynergism

More Related Videos

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.4K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.5K

Related Experiment Videos

Last Updated: Jun 18, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.4K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.5K

Area of Science:

  • Epidemiology
  • Biostatistics
  • Pharmacology

Background:

  • Additive interaction is key for assessing synergistic effects in disease prevention.
  • Relative Excess Risk due to Interaction (RERI) is standard for risk factors.
  • Current methods need extension for evaluating preventive factors like drugs.

Purpose of the Study:

  • Introduce and describe the Relative Risk Reduction due to Interaction (RRRI).
  • Assess additive interaction between preventive factors, including drug combinations.
  • Provide a more interpretable measure for synergistic effects of interventions.

Main Methods:

  • Defined RRRI as a key metric for additive interaction of preventive factors.
  • Re-evaluated a study on statins and blood pressure drugs for cardiovascular events.
  • Utilized simulation studies with Poisson regression to evaluate RRRI estimation.

Main Results:

  • Drug combination showed positive additive interaction in reducing cardiovascular events (RRRI > 0).
  • RRRI provided a more straightforward interpretation compared to RERI.
  • Simulations emphasized the need for large sample sizes to detect significant interactions.

Conclusions:

  • Recommend RRRI as the primary measure for additive interaction of protective exposures.
  • RRRI is valuable for assessing synergistic effects of drug combinations and preventive treatments.
  • Clearer interpretation of interaction effects in preventive medicine is crucial.